New Trends in Treatment-Resistant Depression

This presentation has been designated as Mental Health Awareness credit.

Sam J. Collier, MD

Associate Professor
Director, Treatment Resistant Depression IPU

Department of Psychiatry

Dell Medical School, The University of Texas at Austin

Learning Objectives

Define Tx-Resistant Depression
Review evidence based drug therapy including augmentation strategies
Explore Ketamine use and monitoring requirements (REM's)

Activity Description

This program consists of 1 video and downloadable resources in PDF format. To begin, take the ungraded pre-test for the module below. Review the video and handout(s), then complete the post-test ( > 70% within 5 attempts) and evaluation. CPE credit will automatically upload to CPE Monitor (allow 7 days).

Continuing Education Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.10 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must complete the online pre-test (ungraded), watch the included video in its entirety, pass the online post-test ( > 70% within 5 attempts), and complete the online evaluation. Upon successful completion of the course evaluation, continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 7 days).

Please make sure NABP profile ID and date of birth (month/year) are entered correctly under learner's profile in this system.

Fee

$10.00

CE Hours

1.00

CE Units

0.100

Activity Type

Knowledge

Target Audience(s)

Pharmacists

New Trends in Treatment-Resistant Depression

About the Faculty

Sam J. Collier, MD
Associate Professor
Director, TreatmentResistant Depression IPU
Department of Psychiatry
Dell Medical School, The University of Texas at Austin

Sam Collier, M.D., is a psychiatrist and faculty member in the Department of Psychiatry at Dell Medical School. His outpatient clinical work is based both at Seton Mind Institute, part of the Ascension Seton Family of Hospitals,and UT Health Austin. Currently, he serves as the Clinical Director for ECT at Ascension Seton Medical Center, Director of theTreatment-Resistant Depression Integrated Practice Unit at Dell Medical School, Chief of Staff at Seton Shoal Creek Hospital, and neuropsychiatric consultant to the Seton Brain and Spine Comprehensive Epilepsy Program. He specializes in the evaluation and treatment of complex neuropsychiatric patients, treatment-resistant mood disorders and neuromodulation. He also teaches psychiatryresidents in the Dell Medical School Psychiatry Residency Program. During medical school training, he developed a deep respect for the importance of meaningful doctor-patient relationships, community outreach, cultural sensitivity and immigrant health. Mental health care offered the best balance of long term relational depth, interpersonal meaning and evolving discovery in neuroscience, so he chose to pursue psychiatric training. He matriculated to the University of Pennsylvania Psychiatric Residency Program, developing expertise in treatment-resistant mood disorders, neuromodulation, cognitive-behavioral therapy and psychoanalytic psychotherapy. After graduation, Dr. Collier returned to Austin to develop the psychiatric training arm for Dell Medical School. After five years of work, the medical school opened in 2016 with its inaugural class of 50 students.

Disclosure: Sam Collier, M.D., has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.

Activity Number

0067-0000-20-130-H01-P/T

Release Date: Sep 26, 2020

Credit Expiration Date: Sep 23, 2023

CE Hours

1.00